Provided by Tiger Trade Technology Pte. Ltd.

Aktis Oncology

18.90
+0.49002.66%
Post-market: 18.50-0.4000-2.12%18:42 EST
Volume:249.29K
Turnover:4.69M
Market Cap:992.67M
PE:- -
High:19.50
Open:18.22
Low:17.90
Close:18.41
52wk High:29.16
52wk Low:16.80
Shares:52.52M
Float Shares:17.65M
Volume Ratio:1.72
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-62.4570
ROE:-26.50%
ROA:-14.80%
PB:-7.50
PE(LYR):-0.30

Loading ...

Company Profile

Company Name:
Aktis Oncology
Exchange:
NASDAQ
Establishment Date:
2020
Employees:
76
Office Location:
17 Drydock Avenue,Suite 17-401,Boston,Massachusetts,United States
Zip Code:
02210
Fax:
- -
Introduction:
Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., designs, develops, manufactures, and sells radio frequency (RF) filter products for the wireless industry in the Americas, Asia, Europe, and internationally. It operates in two segments, Fabrication Services and RF Filters. The Fabrication Services segment provides engineering review and backend packaging services. The RF Filters segment sells amplifier and filter products. It offers RF filters for the wireless industry, such as smartphones and tablets, cellular infrastructure equipment, Wi-Fi customer premise equipment, and military and defense applications. The company also sells complementary surface acoustic wave resonators, crystal (Xtal) resonators and oscillators, and ceramic products; and provides back-end semiconductor supply chain services. Akoustis Technologies, Inc. is headquartered in Huntersville, North Carolina.

Directors

Name
Position
Matthew Roden
President, Chief Executive Officer and Director
Andrew Levin
Independent Director
Helen S. Kim
Independent Director
Ken Herrmann
Independent Director
Lloyd M. Segal
Independent Director
Mary Thistle
Independent Director
Michael A. Sherman
Independent Director
Oleg Nodelman
Independent Director
Todd Foley
Chair of the Board

Shareholders

Name
Position
Matthew Roden
President, Chief Executive Officer and Director
Shulamit Ron Bigger
Chief Operating Officer
Kyle D. Kuvalanka
Chief Financial Officer
Akos Czibere
Chief Medical Officer
Paul L. Feldman
Chief Scientific Officer
Tyler Benedum
Chief Technical Officer